Analyst Research: Threshold Pharmaceuticals Inc (THLD.OQ)
THLD.OQ on NASDAQ Stock Exchange Capital Market
5.30USD
1 Aug 2013
5.30USD
1 Aug 2013
Price Change (% chg)
$-0.12 (-2.21%)
$-0.12 (-2.21%)
Prev Close
$5.42
$5.42
Open
$5.48
$5.48
Day's High
$5.48
$5.48
Day's Low
$5.26
$5.26
Volume
125,670
125,670
Avg. Vol
127,854
127,854
52-wk High
$9.28
$9.28
52-wk Low
$3.95
$3.95
| Name | Age | Since | Current Position |
|---|---|---|---|
Harold Selick |
57 | Chief Executive Officer, Director | |
Stewart Kroll |
54 | 2011 | Senior Vice President - Biostatistics and Clinical Operations |
Mark Matteucci |
59 | 2007 | Senior Vice President - Discovery Research |
Joel Fernandes |
43 | 2011 | Vice President - Finance, Controller |
Tillman Pearce |
56 | 2012 | Chief Medical Officer |

